355 related articles for article (PubMed ID: 11914596)
1. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?
Gaibar M; Fernández G; Romero-Lorca A; Novillo A; Tejerina A; Bandrés F; Fernández-Santander A
Int J Biol Markers; 2013 Dec; 28(4):e371-6. PubMed ID: 23828408
[TBL] [Abstract][Full Text] [Related]
3. Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?
Heikkinen AM; Niskanen L; Ryynänen M; Komulainen MH; Tuppurainen MT; Parviainen M; Saarikoski S
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):402-7. PubMed ID: 9974425
[TBL] [Abstract][Full Text] [Related]
4. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
Saarto T; Blomqvist C; Ehnholm C; Taskinen MR; Elomaa I
J Clin Oncol; 1996 Feb; 14(2):429-33. PubMed ID: 8636753
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E4 allele influences the response of plasma triglyceride levels to tamoxifen in breast cancer patients.
Chang NW; Chen FN; Wu CT; Lin CF; Chen DR
Clin Chim Acta; 2009 Mar; 401(1-2):144-7. PubMed ID: 19103187
[TBL] [Abstract][Full Text] [Related]
6. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
Wasan KM; Ramaswamy M; Haley J; Dunn BP
J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
[TBL] [Abstract][Full Text] [Related]
7. The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer.
Montagnani A; Gonnelli S; Cadirni A; Caffarelli C; Del Santo K; Pieropan C; Campagna MS; Montomoli M; Petrioli R; Nuti R
Eur J Intern Med; 2008 Dec; 19(8):592-7. PubMed ID: 19046724
[TBL] [Abstract][Full Text] [Related]
8. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
[TBL] [Abstract][Full Text] [Related]
9. The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.
Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Cufer T; Lobelle JP; Mattiaci MR; Piccart M; Paridaens R
Ann Oncol; 2004 Feb; 15(2):211-7. PubMed ID: 14760111
[TBL] [Abstract][Full Text] [Related]
10. Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer.
Joensuu H; Holli K; Oksanen H; Valavaara R
Breast Cancer Res Treat; 2000 Oct; 63(3):225-34. PubMed ID: 11110056
[TBL] [Abstract][Full Text] [Related]
11. Effects of apolipoprotein E genotype on dietary-induced changes in high-density lipoprotein cholesterol in obese postmenopausal women.
Nicklas BJ; Ferrell RE; Bunyard LB; Berman DM; Dennis KE; Goldberg AP
Metabolism; 2002 Jul; 51(7):853-8. PubMed ID: 12077730
[TBL] [Abstract][Full Text] [Related]
12. Effect of letrozole on the lipid profile in postmenopausal women with breast cancer.
Elisaf MS; Bairaktari ET; Nicolaides C; Kakaidi B; Tzallas CS; Katsaraki A; Pavlidis NA
Eur J Cancer; 2001 Aug; 37(12):1510-3. PubMed ID: 11506958
[TBL] [Abstract][Full Text] [Related]
13. Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels.
Babu JR; Sundravel S; Arumugam G; Renuka R; Deepa N; Sachdanandam P
Cancer Lett; 2000 Apr; 151(1):1-5. PubMed ID: 10766415
[TBL] [Abstract][Full Text] [Related]
14. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
Esteva FJ; Hortobagyi GN
Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
[TBL] [Abstract][Full Text] [Related]
15. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study.
Grönroos P; Raitakari OT; Kähönen M; Hutri-Kähönen N; Marniemi J; Viikari J; Lehtimäki T
Clin Chem Lab Med; 2007; 45(5):592-8. PubMed ID: 17484618
[TBL] [Abstract][Full Text] [Related]
16. Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer.
Kusama M; Miyauchi K; Aoyama H; Sano M; Kimura M; Mitsuyama S; Komaki K; Doihara H
Breast Cancer Res Treat; 2004 Nov; 88(1):1-8. PubMed ID: 15538040
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer.
Morales M; Santana N; Soria A; Mosquera A; Ordovás J; Nóvoa J; Betancor P; Valerón PF; Díaz-Chico B; Chirino R
Breast Cancer Res Treat; 1996; 40(3):265-70. PubMed ID: 8883969
[TBL] [Abstract][Full Text] [Related]
18. Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.
Wasan KM; Goss PE; Pritchard PH; Shepherd L; Tu D; Ingle JN
Breast Cancer Res Treat; 2012 Dec; 136(3):769-76. PubMed ID: 23089983
[TBL] [Abstract][Full Text] [Related]
19. The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.
Hozumi Y; Suemasu K; Takei H; Aihara T; Takehara M; Saito T; Ohsumi S; Masuda N; Ohashi Y
Ann Oncol; 2011 Aug; 22(8):1777-82. PubMed ID: 21285133
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum lipid and lipoprotein levels in postmenopausal patients with node-positive breast cancer treated with tamoxifen.
Vrbanec D; Reiner Z; Belev B; Plestina S
Tumori; 1998; 84(6):687-90. PubMed ID: 10080678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
